ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements with these filters
Max Healthcare Institute Ltd issued a postal ballot notice to seek shareholder approval for its 2026 ESOP scheme, director remuneration, and alterations to its objects clause.
Max Healthcare has received an ESG rating of '72' from Niche99, a SEBI-registered provider. This independent rating places the company in the 'Leader' category.
Max Healthcare disclosed an update on ongoing NCLT proceedings initiated by BRS Capital against its subsidiary. The next hearing is scheduled for September 28, 2026.
Max Healthcare Institute Limited has allotted 33,765 equity shares under its ESOP scheme. This increases the total paid-up share capital to 973,310,251 equity shares.
Max Healthcare allotted 33,765 equity shares under its Employee Stock Option Scheme 2022. The allotment was made at an exercise price of ₹350 per share.
Max Healthcare Institute Limited approved an additional investment of Rs. 87.87 Crore in its subsidiary, Kalinga Hospital Limited. The funds will support capital expenditure and modernization programs.
Max Healthcare inaugurated a new 400-bed tower at its Saket facility, increasing the site's total capacity to 1,200 beds. The expansion establishes it as Delhi's largest private hospital.
Max Healthcare Q1 FY27 revenue grew 16% YoY to INR 2,982 Cr. Operating EBITDA rose 15% to INR 704 Cr. Strategy focuses on aggressive brownfield expansions and entering the medical education business.
Max Healthcare delivered strong Q1 FY27 results with Net Revenue growing 15% YoY to ₹2,835 Cr and Operating EBITDA rising 15% to ₹704 Cr, driven by improved ARPOB and occupancy.
Max Healthcare Institute Ltd reported revenue from operations of ₹2,366 Cr (+16.7% YoY) and net profit of ₹323 Cr (+4.9% YoY) for Q1 FY27.